(Q42549416)

English

Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents

scientific article published on May 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

1 reference

based on heuristic

inferred from title

author name string

Iatsimirskaia E

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Tulebaev S

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Storozhuk E

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Utkin I

4

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Smith D

5

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Gerber N

6

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Koudriakova T

7

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

language of work or name

0 references

publication date

1 May 1997

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

61

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

554-562

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Pharmacokinetics of rifabutin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

21 January 2018

Cyclosporin-erythromycin interaction in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

21 January 2018

Increased plasma rifabutin levels with concomitant fluconazole therapy in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

21 January 2018

The determination of enzyme inhibitor constants

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

21 January 2018

Autoinduction of rifabutin metabolism in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Absorption, disposition and preliminary metabolic pathway of 14C-rifabutin in animals and man.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Urinary metabolites of rifabutin, a new antimycobacterial agent, in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Identification of urinary metabolites of rifamycin LM 427 in man

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Cyclosporin metabolism in transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Azoles, a48 llylamines and drug metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Rifabutin-associated uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Fluconazole and enhanced effect of rifabutin prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

In vitro systems for prediction of rates of drug clearance and drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Drug interactions and interindividual variability of ciclosporin metabolism in the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Vertical banded gastroplasty for obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Non-inverted versus inverted plots in enzyme kinetics

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

First-pass metabolism of midazolam by the human intestine.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Clinical significance of esterases in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Clarithromycin pharmacokinetics in healthy young and elderly volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Clinical pharmacokinetics of fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

Clinical pharmacokinetics of ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

The pharmacokinetics of ketoconazole after chronic administration in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

New rifamycins modified at positions 3 and 4. Synthesis, structure and biological evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990135-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0009-9236(97)90135-1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42549416&oldid=1961347128"